| Dr Dennis Anthony Porto, MD | |
|
1 Maple Street, 2nd Floor, Milford, MA 01757 | |
| (508) 478-2610 | |
| Not Available |
| Full Name | Dr Dennis Anthony Porto |
|---|---|
| Gender | Male |
| Speciality | Micrographic Dermatologic Surgery (mds) |
| Experience | 11 Years |
| Location | 1 Maple Street, Milford, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689012510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207NS0135X | Dermatology - Procedural Dermatology | 271027 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Schweiger Dermatology Pllc | 5991947160 | 178 |
News Archive
Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.
Vegan school lunches contain triple the amount of heart-healthy fiber found in standard entrées, according to a new case study published in The Journal of Child Nutrition & Management. Fiber is an important nutrient that not only aids heart health, but also boosts digestion, weight loss, and cancer prevention.
Hiding deep inside the bone marrow are special cells. They wait patiently for the hour of need, at which point these blood forming stem cells can proliferate and differentiate into billions of mature blood immune cells to help the body cope with infection, for example, or extra red blood cells for low oxygen levels at high altitudes. Even in emergencies, however, the body keeps to a long-term plan: It maintains a reserve of undifferentiated stem cells for future needs and crises.
Advanced Cell Technology, Inc. announced today that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in connection with the Company's plans to initiate a Phase I/II multicenter study using embryonic stem (ES) cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
There are millions living with HIV and researchers have been working towards making a successful vaccine against the deadly infection for the past 35 years with no success. Now a new blueprint is being developed to prevent the infection.
› Verified 2 days ago
| Entity Name | Schweiger Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831438662 PECOS PAC ID: 5991947160 Enrollment ID: O20130819000251 |
News Archive
Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.
Vegan school lunches contain triple the amount of heart-healthy fiber found in standard entrées, according to a new case study published in The Journal of Child Nutrition & Management. Fiber is an important nutrient that not only aids heart health, but also boosts digestion, weight loss, and cancer prevention.
Hiding deep inside the bone marrow are special cells. They wait patiently for the hour of need, at which point these blood forming stem cells can proliferate and differentiate into billions of mature blood immune cells to help the body cope with infection, for example, or extra red blood cells for low oxygen levels at high altitudes. Even in emergencies, however, the body keeps to a long-term plan: It maintains a reserve of undifferentiated stem cells for future needs and crises.
Advanced Cell Technology, Inc. announced today that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in connection with the Company's plans to initiate a Phase I/II multicenter study using embryonic stem (ES) cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
There are millions living with HIV and researchers have been working towards making a successful vaccine against the deadly infection for the past 35 years with no success. Now a new blueprint is being developed to prevent the infection.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dennis Anthony Porto, MD 200 Brookline Ave Unit 707, Boston, MA 02215-3953 Ph: (508) 478-2610 | Dr Dennis Anthony Porto, MD 1 Maple Street, 2nd Floor, Milford, MA 01757 Ph: (508) 478-2610 |
News Archive
Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.
Vegan school lunches contain triple the amount of heart-healthy fiber found in standard entrées, according to a new case study published in The Journal of Child Nutrition & Management. Fiber is an important nutrient that not only aids heart health, but also boosts digestion, weight loss, and cancer prevention.
Hiding deep inside the bone marrow are special cells. They wait patiently for the hour of need, at which point these blood forming stem cells can proliferate and differentiate into billions of mature blood immune cells to help the body cope with infection, for example, or extra red blood cells for low oxygen levels at high altitudes. Even in emergencies, however, the body keeps to a long-term plan: It maintains a reserve of undifferentiated stem cells for future needs and crises.
Advanced Cell Technology, Inc. announced today that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in connection with the Company's plans to initiate a Phase I/II multicenter study using embryonic stem (ES) cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
There are millions living with HIV and researchers have been working towards making a successful vaccine against the deadly infection for the past 35 years with no success. Now a new blueprint is being developed to prevent the infection.
› Verified 2 days ago
Dr. Tracey Adams Chessare, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1 Maple St, Milford, MA 01757 Phone: 508-478-2610 Fax: 508-478-2667 | |
Dr. Lee S Albert, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 258 Main St, Suite 302, Milford, MA 01757 Phone: 508-473-2321 Fax: 508-473-2327 | |
Dr. Ganary Dabiri, MD/PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1 Maple St, Milford, MA 01757 Phone: 508-478-2610 Fax: 508-478-2667 |